Investor Overview
VYNE Therapeutics™ is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.26
Feb. 03, 2023 16:00:04- Change -0.0037 (-1.4286%)
- Volume 242,152
- Today's Open 0.27
- Previous Close 0.259
- Today's High 0.27
- Today's Low 0.2541
- 52 Week High 0.79
- 52 Week Low 0.111